ClinicalTrials.Veeva

Menu

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

U

University Hospital Tuebingen

Status

Enrolling

Conditions

Uterine Neoplasms

Treatments

Diagnostic Test: uterine neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT03624712
ZGynO_DENOVA

Details and patient eligibility

About

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm

Enrollment

580 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)
  • If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery
  • Written consent
  • Willingness and ability to participate in all study-specific procedures
  • Age ≥ 18 years

Exclusion criteria

  • Severe and acute general disease in the last 4 weeks
  • Acute or chronic psychiatric disorders
  • Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)

Trial design

580 participants in 1 patient group

uterine neoplasms
Description:
Women with operable and inoperable uterine malignomas (cervical cancer, endometrial cancer, uterine sarcoma)
Treatment:
Diagnostic Test: uterine neoplasms

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems